SeekingAlpha · Aug 7, 2026
Privia Health Group, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-07. The following slide deck was published by Privia Health Group, Inc.
NASDAQ · PRVA
Healthcare · Medical - Healthcare Information Services
$20.86
Down-$0.21 (-1.00%)
Updated Aug 28, 2026, 8:59 AM
SID Score
3.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
PRVA closed at $20.86 after 21 trading sessions, down 12.57% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $21.05 | $21.185 | $20.82 | $20.86 | 943.54K |
| Aug 26, 2026 | $21.15 | $21.49 | $21.05 | $21.07 | 724.82K |
| Aug 25, 2026 | $21.04 | $21.23 | $20.82 | $21.20 | 983.97K |
| Aug 24, 2026 | $21.12 | $21.39 | $20.945 | $21.02 | 876.61K |
| Aug 21, 2026 | $21.22 | $21.345 | $21.04 | $21.12 | 914.52K |
| Aug 20, 2026 | $21.27 | $21.71 | $21.015 | $21.20 | 766.5K |
| Aug 19, 2026 | $21.73 | $22.065 | $21.45 | $21.49 | 852.34K |
| Aug 18, 2026 | $21.50 | $21.85 | $21.415 | $21.52 | 929.94K |
| Aug 17, 2026 | $21.84 | $21.98 | $21.44 | $21.50 | 889.32K |
| Aug 14, 2026 | $21.72 | $22.25 | $21.55 | $22.00 | 676.46K |
| Aug 13, 2026 | $21.67 | $21.97 | $21.47 | $21.76 | 1.13M |
| Aug 12, 2026 | $21.98 | $22.03 | $21.26 | $21.54 | 1.69M |
| Aug 11, 2026 | $22.49 | $22.53 | $21.77 | $21.98 | 1.26M |
| Aug 10, 2026 | $22.39 | $22.805 | $22.045 | $22.37 | 1.32M |
| Aug 7, 2026 | $22.06 | $22.59 | $21.5411 | $22.45 | 2.34M |
| Aug 6, 2026 | $20.90 | $22.095 | $19.70 | $22.00 | 4.41M |
| Aug 5, 2026 | $23.79 | $24.46 | $23.56 | $23.96 | 1.2M |
| Aug 4, 2026 | $23.41 | $24.07 | $23.36 | $23.79 | 1.13M |
| Aug 3, 2026 | $23.84 | $24.28 | $23.74 | $23.79 | 642.94K |
| Jul 31, 2026 | $23.59 | $23.765 | $23.41 | $23.67 | 969.2K |
| Jul 30, 2026 | $23.97 | $24.155 | $23.53 | $23.86 | 915.29K |
The latest Smart Investors Daily articles mentioning PRVA.
PRVA research
Company profile and research snapshot.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 26, 2026 | Barclays | Equal-Weight | — |
| May 8, 2026 | Canaccord Genuity | Buy | — |
| Apr 8, 2026 | Evercore ISI Group | Outperform | — |
| Mar 25, 2026 | Barclays | Equal-Weight | — |
| Mar 3, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
2026-08-07. The following slide deck was published by Privia Health Group, Inc.
ChartMill · Aug 6, 2026
Privia Health beats Q2 revenue estimates, EPS in line; stock jumps 16.7% pre-market. Strong execution and growth momentum.
SeekingAlpha · Aug 6, 2026
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call August 6, 2026 8:00 AM EDTCompany ParticipantsRobert Borchert - Senior Vice President of Investor...
Benzinga · Aug 6, 2026
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.07 by 171.43 percent. This is a 11.76 percent increase over earnings of $0.17 per share from
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PRVA.